Ftse Mib
34.249,77
0,91%
DAX
18.161,01
1,32%
S&P 500
5.099,96
1,02%
NASDAQ Composite
15.927,90
2,03%
Bitcoin
63.165,62
-0,90%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Assistenza
Home Investire Azioni U.S.A. NASDAQ Innoviva Inc (INVA) Innoviva Inc (INVA) Notizie

Innoviva Inc

INVA
15,26
0,27 (1,80%)
26 Apr 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
24/4/202413:00BWInnoviva Specialty Therapeutics’ Positive Phase 3 Oral..
08/3/202401:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202401:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202401:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202400:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202423:01EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
29/2/202422:15EDGAR2Form 8-K - Current report
29/2/202422:05BWInnoviva Reports Fourth Quarter and Full Year 2023 Financial..
23/2/202403:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202403:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202413:23EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
23/1/202403:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/1/202402:26EDGAR2Form 3 - Initial statement of beneficial ownership of..
17/11/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/11/202314:30EDGAR2Form 8-K - Current report
01/11/202321:30EDGAR2Form 8-K - Current report
01/11/202321:15BWInnoviva Reports Third Quarter 2023 Financial Results and..
01/11/202321:05BWPositive Results Announced in Largest Pivotal Phase 3 Trial..
19/9/202314:30BWInnoviva to Participate in the Cantor Global Healthcare..
18/9/202314:00BWXACDURO®, The First and Only Antibiotic Developed to Target..
01/9/202302:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/8/202319:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/8/202323:24EDGAR2Form 8-K - Current report
25/8/202322:52BWInnoviva Appoints Stephen Basso as Chief Financial Officer
07/8/202322:42EDGAR2Form 8-K - Current report
03/8/202303:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/8/202322:15EDGAR2Form 8-K - Current report
02/8/202322:05BWInnoviva Reports Second Quarter 2023 Financial Results and..
11/7/202314:16EDGAR2Form 8-K - Current report
06/6/202322:05BWInnoviva to Participate in the Goldman Sachs Annual Global..
24/5/202301:10DJNFDA Approves Innoviva's Bacterial Pneumonia Treatment
24/5/202300:42BWInnoviva Specialty Therapeutics Announces FDA Approval for..
12/5/202300:45BWResults from Pivotal Phase 3 ATTACK Trial of Investigational..
09/5/202322:32BWInnoviva Reports First Quarter 2023 Financial Results and..
28/4/202323:30BWInnoviva Announces Retirement of Board Chairman
Apertura: 15,01 Min: 14,98 Max: 15,285
Chiusura: 14,99

La tua Cronologia

NASDAQ
INVA
Innoviva
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network